62 related articles for article (PubMed ID: 32043772)
1. A Phase II Study of Perioperative Capecitabine plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601).
Terazawa T; Matsuyama J; Goto M; Kawabata R; Endo S; Imano M; Fujita S; Akamaru Y; Taniguchi H; Tatsumi M; Lee SW; Kurisu Y; Kawakami H; Kurokawa Y; Shimokawa T; Sakai D; Kato T; Fujitani K; Satoh T
Oncologist; 2020 Feb; 25(2):119-e208. PubMed ID: 32043772
[TBL] [Abstract][Full Text] [Related]
2. Oxaliplatin plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma in Combination with D2 Gastrectomy: NEO-CLASSIC Study.
Yu Y; Fang Y; Shen Z; Wang Y; Yan M; Cao H; Liu Y; Wang X; Cui Y; Liu F; Chen W; Li W; Li Q; Jiang H; Sun Y; Liu T
Oncologist; 2019 Oct; 24(10):1311-e989. PubMed ID: 31239311
[TBL] [Abstract][Full Text] [Related]
3. Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study.
Kawabata R; Chin K; Takahari D; Hosaka H; Muto O; Shindo Y; Nagata N; Yabusaki H; Imamura H; Endo S; Kashiwada T; Nakamura M; Hihara J; Kobayashi M; Sagawa T; Saito S; Sato A; Yamada T; Okano N; Shimada K; Matsushima M; Kataoka M; Matsumoto S; Goto M; Kotaka M; Shiraishi T; Yamai H; Nagashima F; Ishizuka N; Yamaguchi K
Gastric Cancer; 2023 Nov; 26(6):1020-1029. PubMed ID: 37610558
[TBL] [Abstract][Full Text] [Related]
4. Short-term outcomes of preoperative chemotherapy with docetaxel, oxaliplatin, and S-1 for gastric cancer with extensive lymph node metastasis (JCOG1704).
Kurokawa Y; Doki Y; Kitabayashi R; Yoshikawa T; Nomura T; Tsuji K; Goto M; Cho H; Hihara J; Hiki N; Nunobe S; Mizusawa J; Boku N; Terashima M
Gastric Cancer; 2024 Mar; 27(2):366-374. PubMed ID: 38180622
[TBL] [Abstract][Full Text] [Related]
5. CapeOX perioperative chemotherapy versus postoperative chemotherapy for locally advanced resectable colon cancer: protocol for a two-period randomised controlled phase III trial.
Liu F; Tong T; Huang D; Yuan W; Li D; Lin J; Cai S; Xu Y; Chen W; Sun Y; Zhuang J
BMJ Open; 2019 Jan; 9(1):e017637. PubMed ID: 30700474
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Thrombocytopenia Induced by Capecitabine Plus Oxaliplatin Therapy in Patients With Colorectal Cancer.
Kato N; Nakai T; Kodama S; Koyama S; Nakane S; Wada Y; Oda H; Katayama H; Mase H; Miyagawa Y; Miyazaki M; Yamada S; Yamada K
In Vivo; 2024; 38(3):1243-1252. PubMed ID: 38688620
[TBL] [Abstract][Full Text] [Related]
7. Perioperative TAS-118 plus oxaliplatin in patients with locally advanced gastric cancer: APOLLO-11 study.
Takahari D; Katai H; Takashima A; Izawa N; Ishizuka N; Ohashi M; Mikami S; Wakatsuki T; Nakayama I; Chin K; Ida S; Kumagai K; Nunobe S; Iwasa S; Shoji H; Wada T; Doi A; Yoshikawa T; Sano T; Boku N; Yamaguchi K
Gastric Cancer; 2023 Jul; 26(4):614-625. PubMed ID: 37029843
[TBL] [Abstract][Full Text] [Related]
8. Hepatoid adenocarcinoma of the stomach effectively treated with capecitabine with oxaliplatin as adjuvant chemotherapy: A case report and literature review.
Amioka J; Yanagawa S; Yamamoto Y; Nakahara M; Yonehara S; Noriyuki T
Int J Surg Case Rep; 2023 Nov; 112():108963. PubMed ID: 37856969
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant and post-recurrent treatment patterns in patients with resectable gastric cancer in japan: a retrospective database cohort study.
Yoshikawa T; Kikko Y; Makino R; Kimijima Y; Nishiyama E; Matsuda Y; Casaes Teixeira B; Tejada M; Carroll R; Hironaka S
Gastric Cancer; 2024 Apr; ():. PubMed ID: 38689045
[TBL] [Abstract][Full Text] [Related]
10. Preoperative Nutritional Status Contributes to the Development of Neutropenia Event in Patients With Gastric Cancer Receiving CAPEOX Adjuvant Chemotherapy.
Xiao AT; Tong YX; Xu XS; Zhou Y; Zhang S
Front Oncol; 2020; 10():692. PubMed ID: 32426291
[No Abstract] [Full Text] [Related]
11. Thromboembolic events in patients who received adjuvant chemotherapy for gastric cancer: a single-center retrospective study.
Kim TH; Choi JH; Jeon SM; Choi YW; Kwon M; Lee HW; Kang SY; Ahn MS; Son SY; Hur H; Han SU; Sheen SS
Gastric Cancer; 2023 Nov; 26(6):1012-1019. PubMed ID: 37648892
[TBL] [Abstract][Full Text] [Related]
12. Capecitabine and oxaliplatin induced Steven-Johnson syndrome following nivolumab in a patient of metastatic esophageal carcinoma.
Kumar S; Nongkynrih A; Dey B; Jagtap V; Lamba R; Chyrmang D
Int Cancer Conf J; 2024 Apr; 13(2):167-170. PubMed ID: 38524655
[TBL] [Abstract][Full Text] [Related]
13. Effect of CAPEOX combined with thalidomide in the treatment of elderly patients with colon cancer: A single-center report.
Zhong N; Yu Y; Yang P
Asian J Surg; 2024 May; ():. PubMed ID: 38762414
[No Abstract] [Full Text] [Related]
14. Phase II Study of Panitumumab Monotherapy in Chemotherapy-Naïve Frail or Elderly Patients with Unresectable RAS Wild-Type Colorectal Cancer: OGSG 1602.
Terazawa T; Kato T; Goto M; Ohta K; Noura S; Satake H; Kagawa Y; Kawakami H; Hasegawa H; Yanagihara K; Shingai T; Nakata K; Kotaka M; Hiraki M; Konishi K; Nakae S; Sakai D; Kurokawa Y; Shimokawa T; Satoh T
Oncologist; 2021 Jan; 26(1):17-e47. PubMed ID: 32918848
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of 5-fluorouracil-leucovorin plus bevacizumab for chemotherapy-naïve older or frail patients with metastatic colorectal cancer (OGSG 0802).
Ohta T; Kato T; Kawakami H; Miyake Y; Goto M; Iwamoto S; Otsuji T; Nakamura M; Sugimoto N; Okamura S; Kotaka M; Tsujie M; Tokunaga Y; Mishima H; Hata T; Shimokawa T; Kurokawa Y; Satoh T
Int J Clin Oncol; 2020 Jul; 25(7):1291-1298. PubMed ID: 32219630
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of neoadjuvant chemotherapy on patients with advanced gastric cancer: A multicenter randomized clinical trial.
Zhao Q; Lian C; Huo Z; Li M; Liu Y; Fan L; Tan B; Zhao X; Zhang Z; Wang D; Liu Y; Guo H; Yang P; Tian Y; Li Y
Cancer Med; 2020 Aug; 9(16):5731-5745. PubMed ID: 32583567
[TBL] [Abstract][Full Text] [Related]
17. Phase II clinical trial to study the safety and efficacy of combined S-1 + oxaliplatin therapy as neoadjuvant chemotherapy for locally advanced gastric cancer in older patients.
Ota M; Saeki H; Uehara H; Matsuda Y; Tsutsumi S; Kusumoto T; Yasui H; Ubukata Y; Yamaguchi S; Orita H; Izawa N; Kakizoe S; Shimokawa M; Yoshizumi T; Kakeji Y; Mori M; Oki E
Int J Clin Oncol; 2023 Sep; 28(9):1166-1175. PubMed ID: 37368093
[TBL] [Abstract][Full Text] [Related]
18. Combining neoadjuvant chemotherapy with PD-1/PD-L1 inhibitors for locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis.
Yuan Z; Cui H; Wang S; Liang W; Cao B; Song L; Liu G; Huang J; Chen L; Wei B
Front Oncol; 2023; 13():1103320. PubMed ID: 36776290
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant Chemotherapy in Asian Patients With Locally Advanced Gastric Cancer.
Tong X; Zhi P; Lin S
J Gastric Cancer; 2023 Jan; 23(1):182-193. PubMed ID: 36750998
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
